Agilent Technologies balance sheet

At the end of fiscal 2025, Agilent Technologies had total assets of $12.73bn, total liabilities of $5.99bn and shareholders' equity of $6.74bn. It held $1.79bn in cash against $3.35bn of debt: net debt of $1.56bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Agilent Technologies: balance sheet, annual
Fiscal year	2009Oct 2009	2010Oct 2010	2011Oct 2011	2012Oct 2012	2013Oct 2013	2014Oct 2014	2015Oct 2015	2016Oct 2016	2017Oct 2017	2018Oct 2018	2019Oct 2019	2020Oct 2020	2021Oct 2021	2022Oct 2022	2023Oct 2023	2024Oct 2024	2025Oct 2025	LTMJul 2026
Cash and equivalents	2.5	2.6	3.5	2.4	2.7	2.2	2.0	2.3	2.7	2.2	1.4	1.4	1.5	1.1	1.6	1.3	1.8	1.8
Receivables	0.6	0.9	0.9	0.9	0.9	0.6	0.6	0.6	0.7	0.8	0.9	1.0	1.2	1.4	1.3	1.3	1.5	1.5
Inventory	0.6	0.7	0.9	1.0	1.1	0.6	0.5	0.5	0.6	0.6	0.7	0.7	0.8	1.0	1.0	1.0	1.0	1.1
Total current assets	4.0	6.2	5.6	4.6	5.0	5.5	3.7	3.6	4.2	3.9	3.2	3.4	3.8	3.8	4.2	4.0	4.6	4.7
Goodwill	0.7	1.5	1.6	3.0	2.6	2.5	2.4	2.5	2.6	3.0	3.6	3.6	4.0	4.0	4.0	4.5	4.5	5.0
Total assets	7.6	9.7	9.1	10.5	10.7	10.8	7.5	7.8	8.4	8.6	9.5	9.6	10.7	10.5	10.8	11.8	12.7	14.0
Accounts payable	0.3	0.5	0.5	0.5	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.4	0.6	0.4	0.5	0.6	0.6
Deferred revenue (current)	0.3	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.5	0.5	0.5	0.6	0.6
Total current liabilities	1.1	3.1	1.8	1.9	1.6	1.7	1.0	0.9	1.3	1.2	2.1	1.5	1.7	1.9	1.6	1.9	2.3	2.3
Short-term debt	0.0	1.5	0.3	0.3	0.0	—	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.3
Long-term debt	2.9	2.2	1.9	2.1	2.7	1.7	1.7	1.9	1.8	1.8	1.8	2.3	2.7	2.7	2.7	3.3	3.1	3.6
Total debt	2.9	3.7	2.2	2.4	2.7	1.7	1.7	1.9	2.0	1.8	2.4	2.4	2.7	2.8	2.7	3.4	3.4	3.9
Total liabilities	5.1	6.5	4.7	5.4	5.4	5.5	3.3	3.5	3.6	4.0	4.7	4.8	5.3	5.2	4.9	5.9	6.0	6.6
Shareholders' equity	2.5	3.2	4.3	5.2	5.3	5.3	4.2	4.2	4.8	4.6	4.7	4.9	5.4	5.3	5.8	5.9	6.7	7.4
Net debt (negative = net cash)	0.4	1.0	−1.3	0.0	0.0	−0.6	−0.3	−0.4	−0.7	−0.4	1.0	0.9	1.2	1.7	1.1	2.1	1.6	2.2
Shares outstanding	—	—	—	—	—	—	—	—	322m	318m	309m	306m	302m	295m	292m	285m	283m	282m

US$ billions unless shown otherwise. Fiscal quarters.

Agilent Technologies: balance sheet, quarterly
Quarter	2024 Q4Oct 2024	2025 Q1Jan 2025	2025 Q2Apr 2025	2025 Q3Jul 2025	2025 Q4Oct 2025	2026 Q1Jan 2026	2026 Q2Apr 2026	2026 Q3Jul 2026
Receivables	1.3	1.3	1.4	1.4	1.5	1.5	1.5	1.5
Inventory	1.0	1.0	1.0	1.0	1.0	1.1	1.1	1.1
Total current assets	4.0	4.1	4.2	4.3	4.6	4.6	4.8	4.7
Goodwill	4.5	4.4	4.5	4.5	4.5	4.5	4.5	5.0
Total assets	11.8	11.9	12.2	12.2	12.7	12.8	13.1	14.0
Accounts payable	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.6
Deferred revenue (current)	0.5	0.6	0.6	0.6	0.6	0.7	0.7	0.6
Total current liabilities	1.9	1.9	2.0	1.9	2.3	2.2	2.3	2.3
Short-term debt	0.0	0.0	0.1	0.1	0.3	0.3	0.3	0.3
Long-term debt	3.3	3.3	3.3	3.4	3.1	3.1	3.1	3.6
Total debt	3.4	3.4	3.5	3.4	3.4	3.4	3.4	3.9
Total liabilities	5.9	5.9	6.0	5.9	6.0	5.9	5.9	6.6
Shareholders' equity	5.9	6.0	6.1	6.4	6.7	6.9	7.1	7.4
Shares outstanding	285m	285m	284m	284m	283m	283m	282m	282m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: A vs AVTR A vs ICLR A vs WAT

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Agilent Technologies's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Agilent Technologies.